Cytokine production by human colonic intraepithelial lymphocytes in controls and ulcerative colitis

P Hoang1, H R Dalton, H J de Silv

  • 1Service de Gastro-Enterologie Université Catholique de Louvain Bruxelles Belgium.

Insights

Colonic intraepithelial lymphocytes produce low levels of gamma-interferon and interleukin-2 when stimulated. This study found no significant difference in cytokine production between control and inflammatory bowel disease patients.

Area of Science:

  • Immunology
  • Gastroenterology

Background:

  • Colonic intraepithelial lymphocytes (IELs) play a crucial role in mucosal immunity.
  • Understanding IEL cytokine production is vital for inflammatory bowel disease (IBD) research.

Purpose of the Study:

  • To quantify gamma-interferon and interleukin-2 production by IELs.
  • To compare IEL cytokine responses in healthy individuals versus IBD patients.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure cytokine concentrations.
  • IELs were cultured with or without phytohaemagglutinin (PHA) stimulation.

Main Results:

  • PHA stimulation significantly increased gamma-interferon and interleukin-2 production by IELs (p < 0.05).
  • No significant differences in cytokine production were observed between control and IBD IELs.

Conclusions:

  • IELs exhibit a measurable, albeit low, production of gamma-interferon and interleukin-2 upon PHA stimulation.
  • IEL cytokine production profiles, as measured in this study, do not differentiate between control and IBD states.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...